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The cellular heterogeneity of the brain confounds
efforts to elucidate the biological properties of dis-
tinct neuronal populations. Using bacterial artificial
chromosome (BAC) transgenic mice that express
EGFP-tagged ribosomal protein L10a in defined cell
populations, we have developed a methodology for
affinity purification of polysomal mRNAs from genet-
ically defined cell populations in the brain. The utility
of this approach is illustrated by the comparative
analysis of four types of neurons, revealing hundreds
of genes that distinguish these four cell populations.
We find that even two morphologically indistinguish-
able, intermixed subclasses of medium spiny neu-
rons display vastly different translational profiles
and present examples of the physiological signifi-
cance of such differences. This genetically targeted
translating ribosome affinity purification (TRAP)
methodology is a generalizable method useful for
the identification of molecular changes in any genet-
ically defined cell type in response to genetic alter-
ations, disease, or pharmacological perturbations.
INTRODUCTION
A century ago, Ramo´n y Cajal used Golgi staining to show
that distinct cells called neurons are a major component of the
mammalian central nervous system (CNS) (Ramo´n y Cajal et al.,
1899). Today, hundreds of neuronal subtypes have been de-
fined, but a molecular description of each subtype has been
hampered by the same problems faced by Ramo´n y Cajal and
his contemporaries: neuronal subtypes are highly heteroge-
neous and intermixed. Numerous attempts to extend microarray
analysis of gene expression to defined cell populations in the738 Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc.CNS have relied upon the physical enrichment of target cell
populations with laser-capture microdissection (LCM) or fluores-
cence-activated cell sorting (FACS) of acutely dissociated
primary neurons. Unfortunately, these studies have been limited
by stresses introduced during cellular isolation procedures,
adaptations that occur upon loss of tissue-intrinsic signals,
and the technical challenges associated with RNA purification
from fixed tissue. To circumvent these problems, we have devel-
oped a direct, rapid affinity purification strategy for isolation of
polysomal RNA from genetically targeted cell types.
We describe here a new translating ribosome affinity purifica-
tion (TRAP) methodology, which readily and reproducibly
identifies translated mRNAs in any cell type of interest. This
methodology involves expression of an EGFP-L10a ribosomal
transgene, which enables tagging of polysomes for immunoaf-
finity purification of mRNA, in specific cell populations with
bacterial artificial chromosome (BAC) transgenic mice, allowing
CNS translational profiling from whole animals. Because of their
ability to carry large pieces of regulatory information, BACs can
be used to reproduce the expression pattern of a gene of inter-
est. Indeed, a large number of BAC vectors driving expression
in specific CNS cell types have been characterized as part of
the Gene Expression Nervous System Atlas (GENSAT) project
(Gong et al., 2003). BAC transgenic lines generated for the TRAP
methodology, with the EGFP-L10a transgene, are referred to
here as bacTRAP lines.
We illustrate the power of this approach in a study of four
distinct neuronal populations. These include striatonigral and
striatopallidal medium spiny neurons (MSNs), which are inter-
mixed, indistinguishable in somatodendritic morphology, and
of major interest because of their role in the etiology of various
neurological and psychiatric diseases, including Parkinson’s dis-
ease, schizophrenia, attention deficit hyperactivity disorder,
drug addiction, and Huntington’s disease. In the accompanying
paper (Doyle et al., 2008), we describe the generation, character-
ization, and analysis of multiple additional genetically labeled
lines as a resource for studies on a wide variety of CNS cell types.
RESULTS
A Genetically Targeted Translational Profiling
Methodology
Because all mRNAs translated into protein are at one point at-
tached to a ribosome or polyribosome complex (polysome), we
reasoned that an affinity tag fused to a ribosomal protein would
allow isolation of bound mRNAs. We therefore screened fusions
of ribosomal proteins with enhanced green fluorescent protein
(EGFP) for efficient incorporation into polysomes to provide an
immunoaffinity tag for all translated cellular mRNAs (schematic,
Figure 1A). EGFP was chosen because preliminary screens us-
ing small epitope tags were unsatisfactory and because visuali-
zation of EGFP fluorescence provides a simple assay for proper
expression and localization of the fusion protein. After dozens of
candidate ribosomal protein fusions were tested, EGFP fused to
the N terminus of the large-subunit ribosomal protein L10a
(EGFP-L10a) was chosen because its nucleolar and cytoplasmic
localization was consistent with incorporation into intact ribo-
somes and because immunoelectron microscopy data demon-
strated its presence on polysomes (Figure S1 available online
Figure 1. The TRAP Methodology
(A) Schematic of affinity purification of EGFP-
tagged polysomes (originating from the target
cell population; green polysomes) with anti-GFP
antibody-coated beads.
(B) Transmission electron micrographs of anti-
GFP-coated magnetic beads after incubation with
extracts taken from HEK293T cells transfected
with an empty vector (left panel) or the EGFP-L10a
construct (right panel); images were acquired at
50,0003 magnification, with inserts enlarged by
a factor of 2.33.
and data not shown). Prior to the produc-
tion of bacTRAP transgenic mice, prelim-
inary studies in HEK293T cells trans-
fected with EGFP-L10a achieved rapid
and specific immunoaffinity purification
of polysomes (Figure 1B), overall copurifi-
cation of 10% of untagged ribosomal
proteins and ribosomal RNA from cul-
tures in which 30% of cells expressed
EGFP-L10a, and recovery observed for
translated, and not untranslated, mRNAs
(Table S1 and Figure S2). As further
validation of the technique, measure-
ments of the well-documented shift in
translational efficiency of Ferritin mRNA
in response to iron treatment were com-
parable with the TRAP methodology or
traditional polysome gradient methods
(Figure S2).
To genetically target expression of
EGFP-L10a to defined CNS cell popula-
tions, we generated BAC transgenic
mice. To tag polysomes in striatonigral
and striatopallidal cells of the mouse striatum, we used homolo-
gous recombination in bacteria to place EGFP-L10a under the
control of either the Drd2 receptor (striatopallidal) or Drd1a re-
ceptor (striatonigral) loci in the appropriate BACs. Striatonigral
MSNs send projection axons directly to the output nuclei of the
basal ganglia, i.e., the substantia nigra and the internal segment
of the globus pallidus (the entopeduncular nucleus in rodents),
whereas striatopallidal MSNs send projection axons to the exter-
nal segment of the globus pallidus. Mouse lines bearing the
TRAP transgene (EGFP-L10a) were generated and screened
by immunohistochemistry for appropriate expression of the
transgene, as judged by known Drd1a and Drd2 receptor ex-
pression patterns. The Drd2 bacTRAP line CP101 showed high-
est transgenic EGFP-L10a expression in the dorsal and ventral
striatum, olfactory tubercle, and hippocampus, as well as in
the substantia nigra pars compacta and ventral tegmental
area, as expected because of Drd2 autoreceptor expression in
dopaminergic cells (Figure 2A). The Drd1a bacTRAP line CP73
showed highest transgenic EGFP-L10a expression in the dorsal
and ventral striatum, olfactory bulb, olfactory tubercle, and
cortical layers 5 and 6 (Figure 2C). As expected for a ribosomalCell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc. 739
protein fusion, EGFP fluorescence localized to the nucleoli and
cytoplasm (Figure 2B). EGFP direct fluorescence coincident
with enkephalin immunohistochemical detection (striatopallidal
cell marker) was observed in striatal cells from the Drd2 bac-
TRAP line but not the Drd1a bacTRAP line (Figures 2B and 2D),
verifying correct BAC-mediated cell-type expression. Velocity
sedimentation analysis of polysome complexes isolated from
striatal extracts of both bacTRAP lines confirmed incorporation
Figure 2. Expression of EGFP-L10a in Drd1a and Drd2 bacTRAP
Lines
(A) Immunohistochemistry to EGFP in adult sagittal sections from the Drd2
bacTRAP line CP101.
(B) Characterization of Drd2 bacTRAP line CP101 striatal MSN cells: direct
EGFP fluorescence (left panel with high-magnification image insert), enkeph-
alin immunohistochemical staining (middle panel), and merge (right panel,
with 20 mm scale bar).
(C) Immunohistochemistry to EGFP in adult sagittal sections from the Drd1a
bacTRAP line CP73.
(D) Characterization of Drd1a bacTRAP line CP73 striatal MSN cells: direct
EGFP fluorescence (left panel), enkephalin immunohistochemical staining
(middle panel), and merge (right panel).740 Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc.of the EGFP-L10a fusion protein into functional polysomes
in vivo (Figure S3 and data not shown).
We next developed procedures for rapid extraction and immu-
noaffinity purification of the EGFP-tagged polyribosome com-
plexes from intact brain tissue, which proved substantially
more challenging than from transfected cells in culture.
However, after several optimization steps (see the Experimental
Procedures), highly purified RNA was consistently obtained from
bacTRAP mouse brain tissue (Figure 3). Key steps of the purifica-
tion protocol include rapid manual dissection and homogeniza-
tion of the tissue, inclusion of magnesium and cycloheximide in
the lysis buffer to maintain ribosomal subunits on mRNA during
purification, inhibition of endogenous RNase activity, solubiliza-
tion of rough endoplasmic reticulum-bound polysomes under
nondenaturing conditions, use of high-affinity anti-EGFP anti-
bodies, and the addition of high-salt washes after immunoaffinity
purification to reduce background.
Translational Profiling of Striatonigral
and Striatopallidal MSNs
Translational profiling analysis was performed with immunoaffin-
ity-purified mRNA from adult striatonigral or striatopallidal
bacTRAP mice. After two rounds of in vitro transcription, biotin-
labeled antisense RNA (cRNA) was used to interrogate Affyme-
trix GeneChip Mouse Genome 430 2.0 arrays. Replicate
bacTRAP samples collected from each line gave nearly identical
genome-wide translational profiles (average Pearson correlation
of 0.982 and 0.985 for striatonigral and striatopallidal samples,
respectively). For each cell type, data were collected from three
independent biological replicates, each prepared from a cohort
of seven animals. Analysis of immunoaffinity-purified samples
revealed no bias for mRNA length or abundance (Figure S4).
Comparative analysis of these data (see the Experimental Proce-
dures) revealed that all of the well-characterized, differentially
expressed MSN markers (Gerfen, 1992) were enriched with the
TRAP translational profiling approach: dopamine receptor 2
(Drd2) (36.63), adenosine 2a receptor (Adora2a) (13.23), and en-
kephalin (Penk) (7.53) were enriched in the striatopallidal bac-
TRAP sample, whereas dopamine receptor D1A (Drd1a) (3.93),
substance P (Tac1) (3.63), and dynorphin (Pdyn) (5.63) were en-
riched in the striatonigral bacTRAP sample (Figure 3C and Table
S2). We also confirmed four striatopallidal-enriched mRNAs
(Adk, Plxdc1, BC004044, and Hist1h2bc), as well as six striato-
nigral-enriched mRNAs (Slc35d3, Zfp521, Ebf1, Stmn2, Gnb4,
and Nrxn1) reported in a microarray study of FACS-isolated
MSNs (Lobo et al., 2006) (Table S2). We further identified 70
additional striatopallidal-enriched transcripts and more than
150 additional striatonigral-enriched transcripts (Table S2). To
initially verify our data, we performed quantitative PCR assays
using independent biological bacTRAPDrd1a andDrd2 samples
and a different cDNA amplification procedure (see the Supple-
mental Experimental Procedures). Differential translation of
Eya1, Isl1, Gng2, and Crym in striatonigral MSNs and Gpr6,
Lhx8, Gpr88, Trpc4, and Tpm2 in striatopallidal MSNs was con-
firmed (Tables S3 and S4). These genes were selected because
they represent both highly and moderately enriched messages.
Given the apparent enhanced sensitivity of our translational
profiling method, we were next interested in large-scale
Figure 3. Protein and mRNA Purification from bacTRAP Lines
(A) Representative purification of EGFP-tagged L10a and copurification of
untagged ribosomal protein L7 from Drd1a bacTRAP animals but not wild-
type littermates (D1, samples from Drd1a bacTRAP mice; WT, samples from
wild-type littermates; IN, 1% input; UB, 1% unbound; IP, 6.5% immunoaffin-
ity-purified sample). EGFP-L10a signal is only present in the D1 IP lane
because the IP samples were more concentrated relative to IN and UB.
(B) Representative purification of 18S and 28S rRNA from Drd1a bacTRAP
transgenic animals (green) but not wild-type littermates (red) as detected by
Bioanalyzer PicoChips (Agilent Technologies). 28S rRNA runs at 47 s, 18S
rRNA runs at 43 s, and the Picochip marker peak runs at 23 s.
(C) Normalized expression values from Affymetrix Mouse Genome 430 2.0
arrays are plotted for Drd1a and Drd2 bacTRAP samples. The middle diagonal
line represents equal expression, and lines to each side represent 1.5-fold
enrichment in either cell population. Axes are labeled for expression in powers
of 10. The probesets of well-studied genes known to be differentially
expressed are represented in blue.validation of the data with publicly available gene expression
databases. Since in situ hybridization (ISH) alone cannot distin-
guish MSN subtypes, we pooled data from Drd1a and Drd2 bac-
TRAP experiments and compared them to data collected from
the total RNA of one whole brain (minus striatum) (Table S5).
This analysis would be expected to identify most MSN-enriched
transcripts, which can be evaluated in the ISH databases,
whether or not they are differentially expressed in striatopallidal
or striatonigral projection neurons. The analysis resulted in de-
tection of several thousand translated mRNAs enriched in stria-
tum relative to whole brain, including all previously well-known
striatal-enriched genes: Ppp1r1b/Darpp-32 (Walaas and Green-
gard, 1984), Ptpn5/Step (Lombroso et al., 1993), Arpp-19 (Girault
et al., 1990), Arpp-21/RCS (Ouimet et al., 1989), Gnal/Golf (Herve
et al., 1993), Rhes/Rasd2 (Falk et al., 1999), Rgs9 (Gold et al.,
1997), Adcy5 (Glatt and Snyder, 1993), Gng7 (Watson et al.,
1994), Rasgrp2 (Kawasaki et al., 1998), Pde1b (Polli and Kincaid,
1992), Pde10a (Fujishige et al., 1999), Gpr88 (Mizushima et al.,
2000), Rarb (Krezel et al., 1999), and Strn4 (Castets et al., 1996),
as well as the transcription factors Foxp1, Foxp2 (Ferland et al.,
2003), Ebf1 (Lobo et al., 2006), and Zfp503/Nolz (Chang et al.,
2004) (Table S5). Of the first 100 genes appearing in our MSN-
enriched dataset, 26 were present in both of two major gene
expression databases (the GENSAT/Brain Gene Expression Map
[BGEM] and Allen Brain Atlas [ABA] ISH databases [http://www.
ncbi.nlm.nih.gov/projects/gensat/; http://www.stjudebgem.org/]
[Gong et al., 2003; Lein et al., 2007; Magdaleno et al., 2006]),
and enriched striatal expression is evident for 22 of these genes
(Table S5; Figure S5). Thus, TRAP translational profiling can
provide a sensitive tool for discovery of large sets of translated
messages in defined CNS cell populations.
To group striatonigral- and striatopallidal-enriched genes
according to biological function, we looked for statistically over-
represented associations with Gene Ontology (GO) and Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway terms
(Tables S6–S11). GO terms delineate the known molecular func-
tions, biological processes, and cellular localizations (compo-
nents) for a particular gene (Ashburner et al., 2000), whereas
KEGG pathways summarize known molecular interaction and re-
action networks (Kanehisa, 1997). Some differentially translated
mRNAs immediately predicted physiological differences be-
tween striatonigral and striatopallidal cells. For example, among
striatopallidal-enriched mRNAs isGpr6 (Lobo et al., 2007), which
encodes a G protein-coupled receptor for the lysophospholipid
sphingosine 1-phosphate (S1P) (Ignatov et al., 2003). In heterol-
ogous expression systems, S1P activation of Gpr6 receptors in-
duces intracellular Ca2+ release. As intracellular Ca2+ is a crucial
regulator of neuronal physiology, we investigated whether stria-
topallidal enrichment of Gpr6 reflects a differential response to
S1P. To this end, BAC Drd2 striatopallidal or BAC Drd1a striato-
nigral MSNs (expressing soluble EGFP) were identified in brain
slices, patch clamped (Day et al., 2006), loaded with Alexa 594
to visualize dendrites, and loaded with Fluo-4 to monitor intracel-
lular Ca2+ concentration (Figure 4A). A second pipette was then
brought into close physical proximity to a dendrite, 60–80 mm
from the soma, and used to apply S1P (Figures 4A and 4B).
With the somatic membrane potential clamped at 70 mV, focal
application of S1P consistently and reversibly increasedCell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc. 741
Figure 4. Functional Gpr6 Receptors Are
Found in BAC Drd2 Striatopallidal but not
BAC Drd1a Striatonigral Medium Spiny
Neurons
(A) Projection of an EGFP-labeled MSN from
a BAC Drd2 (D2) mouse. The cell was patched
with a pipette containing Alexa 594 (50 mM) for
visualization and Fluo-4 (200 mM) for measuring
changes in intracellular Ca2+ (right). Cells were
voltage clamped at –70 mV. A puffer pipette con-
taining sphingosine 1-phosphate (S1P, 10 mM) was
positioned near a dendrite, 60–80 mm from the
soma (left/cartoon).
(B) High-magnification images of a dendritic seg-
ment (control, left panel) show an increase in
Ca2+ associated with S1P application (S1P puff,
center panel) that reversed with washing (wash,
right panel). The change in Ca2+ was determined
by calculation of the percent change in fluores-
cence of Fluo-4 relative to that of Alexa 594
(DG/R). The blue circle in the first panel indicates
the analyzed region of interest (ROI).
(C) Time course showing the S1P induced in-
crease in intracellular Ca2+ in the ROI from (B)
(orange trace); similar recordings from BAC
Drd1a (D1) MSNs (black trace) or 10 mM thapsigar-
gin loaded BAC Drd2 (D2) MSNs (green trace) did
not reveal any significant changes in dendritic
Ca2+ levels with S1P application.
(D) Box plot summarizing the S1P effects. Percent
increase in fluorescence (DG/R) in BAC Drd2
(D2) MSNs (median = 146%, range 44% to 294%,
n = 6), BAC Drd1a (D1) MSNs (median = 17%,
range 13% to 22%, n = 4), and thapsigargin-
loaded BAC Drd2 (D2) MSNs (median = 4%, range
–9% to 10%, n = 4).dendritic Ca2+ levels in BAC Drd2 striatopallidal neurons (Krus-
kal-Wallis ANOVA, p < 0.01, n = 6) but not in BAC Drd1a striato-
nigral neurons (Kruskal-Wallis ANOVA, p > 0.01, n = 4) (Figures
4C and 4D). Depletion of intracellular Ca2+ stores with the
Ca2+-ATPase inhibitor thapsigargin abolished this response to
S1P (Kruskal-Wallis ANOVA, p > 0.01, n = 4; Figures 4C and
4D). This striatopallidal-specific S1P response would be pre-
dicted to result in a decrease in threonine 34 (T34) phosphoryla-
tion of the centrally important regulatory protein DARPP-32
because of activation of the Ca2+ and calmodulin-dependent
phosphatase calcineurin (Nishi et al., 1999) and/or inhibition of
adenylyl cyclase type 5 (AC5; Adcy5) (Ishikawa et al., 1992; Glatt
and Snyder, 1993). Indeed, a decrease in T34 DARPP-32 phos-
phorylation was seen after 5 min of S1P treatment of striatal sli-
ces (1.04± 0.17 normalized units at 0 min; 0.58± 0.24 normalized
units at 5 min after S1P addition; one-tailed Mann-Whitney test,
p = 0.05, n = 12). These data demonstrate the utility of TRAP
translational profiling in identifying previously unrecognized
functional differences in signaling responses between cell types.
Profiling of Cocaine-Induced Translational Changes
On the basis of the data above, it seemed likely that TRAP trans-
lational profiling could identify molecular responses to genetic,742 Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc.pharmacologic, or environmental changes in single cell types.
To test this idea, we investigated changes in mRNA translation
of MSNs upon pharmacological perturbation of dopaminergic
signaling using cocaine, a competitive inhibitor of the dopamine
transporter, which acts as a psychostimulant by elevating syn-
aptic dopamine levels (Ritz et al., 1987; Di Chiara and Imperato,
1988). Adult mice were treated acutely or chronically with co-
caine or saline and used for translational profiling of striatonigral
(Drd1a) and striatopallidal (Drd2) MSNs. From this analysis, we
identified hundreds of genes whose expression was increased
or decreased in each cell type in response to cocaine (Tables
S12 and S13). It is often difficult to directly compare gene
expression data across drug administration experiments from
published studies because of differences in strain background,
dosing regimen, and assay sensitivity or array platform; in spite
of this, we were able to identify various genes whose expression
has been reported to be affected by cocaine administration,
including: Cartpt (Douglass et al., 1995) (up in acute striatonigral;
Table S12), Fosb (Hope et al., 1992) (up in acute striatonigral and
striatopallidal and chronic striatonigral; Tables S12 and S13),
Homer1 (Brakeman et al., 1997) (up in acute striatonigral and
striatopallidal, chronic striatonigral and striatopallidal; Tables
S12 and S13), Per2 (Yuferov et al., 2003) (up in acute
Figure 5. Cocaine Treatment Increases the Frequency of Small-
Amplitude GABAergic mIPSCs in BAC Drd1a Striatonigral Medium
Spiny Neurons
(A and B) Representative spontaneous mIPSCs traces from BAC Drd1a stria-
tonigral neurons (expressing soluble EGFP under the Drd1a promoter) taken
from mice treated for 15 days with saline (A) or cocaine (20 mg/kg/day) (B).
(C) Bar graph summary of mean mIPSC frequency showing a significant
increase in BAC Drd1a striatonigral neuron mIPSCs frequency after cocaine
treatment (saline = 0.83 ± 0.07 Hz, n = 22; cocaine = 1.04 ± 0.05 Hz, n = 26;
p < 0.05, one-tailed t test).
(D) Bar graph summary showing that the number of small-amplitude mIPSCs
(<75 pA) in equal length records (7 min) increased in BAC Drd1a striatonigral
neurons after cocaine treatment (saline = 79.4 ± 8.2, n = 22; cocaine = 104.2 ±
6.3, n = 26; p < 0.05, one-tailed t test).
(E) Representative variance-mean current plots from saline-treated (black
symbols) and cocaine-treated (red symbols) BAC Drd1a neurons suggesting
that the cocaine-induced small-amplitude events arise from synapses that
have fewer GABAA receptors (N) per synapse but receptors with an unchanged
unitary receptor conductance (g) (saline N = 33, g = 31 pS; cocaine N = 29,
g = 31 pS; see Figures S6C and S6D for means).
(F and G) Representative spontaneous mIPSCs traces from BAC Drd2
striatopallidal neurons after saline treatment for 15 days (F) and after cocaine
treatment for 15 days (G).striatopallidal and chronic striatonigral and chronic striatopalli-
dal; Tables S12 and S13), Vamp2 (McClung and Nestler, 2003)
(up in chronic striatonigral; Table S13), Kcnd2 (McClung and
Nestler, 2003) (up in chronic striatonigral; Table S13), and
Zfp64 (McClung and Nestler, 2003) (up in acute striatopallidal,
down in chronic striatopallidal; Tables S12 and S13).
We looked for statistically overrepresented GO and KEGG
terms (Tables S14–S21) and noted that among the most signifi-
cant GO biological processes altered in Drd1a-expressing stria-
tonigral neurons upon chronic cocaine administration was the
gamma-aminobutyric acid (GABA) signaling pathway (Gabrb3,
Gabra1, Cacnb4, and Gabra4, Table S20). This finding is particu-
larly interesting in light of positron emission tomography (PET)
studies that have documented an enhanced sensitivity to the
benzodiazepine lorazepam (binds GABA receptors) among
chronic cocaine abusers (Volkow et al., 1998). For evaluation of
the possible physiological significance of this upregulation,
mice were chronically treated with cocaine or saline, and
GABAA receptor function was assayed electrophysiologically.
Cocaine treatment significantly increased the frequency of
GABAA receptor miniature inhibitory postsynaptic currents
(mIPSCs) in striatonigral neurons (saline = 0.83 ± 0.07 Hz, n =
22; cocaine = 1.04 ± 0.05 Hz, n = 26; p < 0.05, one-tailed t test;
Figures 5A–5C). Visual inspection of representative records (as
shown in Figures 5A and 5B) suggested that cocaine treatment
increased the frequency of small-amplitude mIPSCs. To evaluate
this possibility, we compiled the amplitude distribution of
mIPSCs. The mode of this distribution was 75 pA in control re-
cordings. Cocaine treatment appeared to shift the mode to
smaller amplitudes. To determine whether the change in the dis-
tribution was significant, we compared equal length records for
the number of submodal (<75 pA) and supramodal (R75 pA)
IPSCs. Cocaine treatment significantly increased the number of
submodal events (saline = 79.4 ± 8.2, n = 22; cocaine = 104.2 ±
6.3, n = 26; p < 0.05, one-tailed t test; Figure 5D) but did not
change the number of supramodal mIPSCs (saline = 81.9 ± 8.6,
n = 22; cocaine = 80.8 ± 7.0, n = 26; p > 0.05, one-tailed t test;
data not shown). The alterations in frequency and amplitude
were not accompanied by a significant change in mIPSC kinetics
(Figures S6A and S6B). Nonstationary noise analysis was also
used to estimate single receptor conductance and the number
of receptors per synapse (De Koninck and Mody, 1994). In neu-
rons from saline-treated animals, the GABAA single receptor con-
ductance was estimated to be 31 pS (Figure 5E; Figure S6C),
a value very near that reported in other cell types (De Koninck
and Mody, 1994; Kilman et al., 2002); cocaine treatment did not
(H) Bar graph summary of mean mIPSC frequency in saline- and cocaine-
treated Drd2 neurons, showing no effect of treatment condition (saline = 0.72 ±
0.05 Hz, n = 12; cocaine = 0.78 ± 0.07 Hz, n = 16; p > 0.05, one-tailed t test).
(I) Bar graph summary showing that the number of small-amplitude mIPSCs
(<75 pA) in equal length records (7 min) was not altered by treatment condition
in BAC Drd2 neurons (saline = 68.1 ± 9.7, n = 12; cocaine = 71.7 ± 7.5, n = 16;
p > 0.05, one-tailed t test).
(J) Representative variance-mean current plots showing that cocaine treat-
ment did not change in the number of receptors per synapse or the unitary
receptor conductance in BAC Drd2 neurons (saline N = 34, g = 31 pS; cocaine
N = 33, g = 30 pS; see Figures S7C and S7D for means).
All error bars represent standard error.Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc. 743
alter this value (saline g = 31.1 ± 1.6, n = 22; cocaine g = 30.8 ±
1.2, n = 26; p > 0.05, one-tailed t test; Figure 5E; Figure S6C).
However, cocaine treatment did significantly reduce the esti-
mated average number of receptors per synapse (saline N =
33.1 ± 1.4, n = 22; cocaine N = 29.3 ± 1.0, n = 26; p < 0.05,
one-tailed t test; Figure 5E; Figure S6D). The most parsimonious
interpretation of these results is that cocaine treatment leads to
(1) the addition of small, dendritic GABAA synapses, resulting in
an increase in mIPSC frequency, and (2) a decrease in the aver-
age number of receptors per synapse, due to dendritic synapses
having fewer receptors than larger somatic synapses.
In contrast to Drd1a-expressing striatonigral neurons, Drd2-
expressing striatopallidal neurons displayed no change in the
frequency (saline = 0.72 ± 0.05 Hz, n = 12; cocaine = 0.78 ±
0.07 Hz, n = 16; p > 0.05, one-tailed t test; Figure 5H), amplitute
(submodal mIPSCs, saline = 68.1 ± 9.7, n = 12; cocaine = 71.7 ±
7.5, n = 16; p > 0.05, one-tailed t test; Figure 5I; supramodal
mIPSCs, saline = 59.1 ± 6.5, n = 12; cocaine = 63.3 ± 4.7, n =
16; p > 0.05, one-tailed t test; data not shown) and kinetics (Fig-
ures S7A and S7B) of GABAA mIPSCs after chronic cocaine
treatment. Likewise, nonstationary noise analysis suggested
that the average receptor conductance and number of receptors
per synapse did not change in Drd2-expressing striatopallidal
neurons after cocaine treatment (Figure 5J and Figures S7C
and S7D). Taken together, these results demonstrate the physi-
ological relevance of the selective cocaine-induced upregulation
of mRNAs associated with GABAA receptors specific to Drd1a-
expressing striatonigral neurons.
Although alterations in GABA release probability could also
cause changes in mIPSC frequency, cocaine treatment altered
the amplitude distribution of GABAA mIPSCs selectively in
Drd1a-expressing striatonigral neurons, which would not be ex-
pected after a blanket increase in GABA release probability. The
preferential increase in small-amplitude mIPSCs and the sug-
gestion from nonstationary noise analysis that the average num-
ber of receptors per synapse fell in striatonigral neurons after co-
caine treatment are consistent with the addition of small
dendritic synapses, as opposed to larger somatic synapses (Ku-
bota and Kawaguchi, 2000). Dendritic GABAergic synapses
arise either from recurrent collaterals of other MSNs or from in-
terneurons (Tepper et al., 2004). Definitively sorting out whether
one or both of these classes contribute to the change in synaptic
properties will require paired cell recordings and ultrastructural
analysis (e.g., Koos et al., 2004; Kubota and Kawaguchi, 2000).
Nevertheless, this upregulation may serve as an adaptive re-
sponse to enhanced excitatory glutamatergic signaling in striato-
nigral neurons associated with the activation of D1 dopamine re-
ceptors by cocaine administration (Flores-Hernandez et al.,
2002; Lee et al., 2006; Valjent et al., 2005; Wolf et al., 2004).
The increased expression of physiologically active, inhibitory
GABAA receptors in striatonigral cells could be a part of the mo-
lecular adaptations underlying the well-documented changes in
sensitivity to cocaine seen among chronic abusers.
Translational Profiling of Cholinergic Motor Neurons
and Purkinje Neurons
To determine whether the TRAP translational profiling methodol-
ogy is generalizable, we produced cholinergic and Purkinjie744 Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc.cell-specific bacTRAP lines. To this end, the EGFP-L10a trans-
gene was placed under the control of the choline acetyltransfer-
ase (Chat) locus, specifically expressed in cholinergic cells in the
CNS, or the Purkinje cell protein 2 (Pcp2) locus, specifically ex-
pressed in cerebellar Purkinje cells of the CNS (Oberdick et al.,
1988). Consistent with known expression patterns, (Oh et al.,
1992), the Chat bacTRAP line DW167 showed highest EGFP-
L10a expression in cholinergic cells of the dorsal and ventral
striatum, basal forebrain, brain stem, spinal cord, and medial ha-
benula (Figure 6A), whereas the Pcp2 bacTRAP line DR166
showed EGFP-L10a expression restricted to cells with charac-
teristic Purkinje cell morphology (Figure 6C). Indirect immunoflu-
orescence staining for Chat and Calbindin-D28K confirmed cell
type-specific expression of theChat andPcp2 lines, respectively
(Figures 6B and 6D). One exception was in the pedunculopontine
and laterodorsal tegmental nuclei, where only a minority of cho-
linergic cells were labeled with EGFP (data not shown).
Array data were collected from brain stem cholinergic motor
neurons and from Purkinje cells with the Chat and Pcp2 bac-
TRAP lines, respectively. Replicate bacTRAP samples gave
nearly identical genome-wide translational profiles (average
Pearson correlation of 0.982 and 0.997, respectively). We identi-
fied mRNAs enriched in each IP sample compared to an arbitrary
reference sample (unbound fractions of the IPs) (Figures 7A–7D).
Enrichment of cell-specific positive-control genes and exclusion
of known negative-control genes (glial genes), were evident for
each comparison (Figures 7A–7D). Venn diagrams constructed
from the top 1000 enriched probesets from this analysis (Tables
S22–S25) showed that the translational profiles of striatonigral
and striatopallidal cells are more similar to each other than to
translational profiles of either brain stem cholinergic cells or Pur-
kinje cells (Figures 7E–7H).
DISCUSSION
TRAP translational profiling combines genetic targeting of an
EGFP-L10a ribosomal fusion protein to specific cell populations;
simple, rapid, affinity purification of mRNA; and microarray tech-
nology to identify translated mRNAs in situ. Unlike traditional ap-
proaches, it combines coincident detection of all translated
mRNAs with cell-type specificity; thus, one quantitative TRAP
experiment can replace thousands of high-throughput qualita-
tive in situ hybridization runs and, further, can be repeated easily
for each experimental condition. Second, the information
obtained is cell type-specific while abrogating the physiologic
adaptations and mRNA degradation that can occur during the
lengthy cell separation procedures used in other approaches
that sever neuronal axons and dendrites and disrupt tissue-
intrinsic signaling. Third, because polysomes are stabilized
with cycloheximide in the extraction buffers and during the affin-
ity purification steps, redistribution of the affinity tag within the
mRNA pool during polysome isolation is prevented, obviating
the problems inherent in using less stable mRNA-binding pro-
teins. Fourth, the use of established bacTRAP lines ensures
that mRNA translation profiles can be reproducibly obtained
and directly compared from the same cell population across
experimental conditions. Crossing of these and other estab-
lished bacTRAP lines to mouse models of various diseases
should greatly facilitate the elucidation of the molecular basis of
disease phenotypes. Fifth, the use of EGFP as the affinity tag
greatly facilitates anatomic studies of candidate bacTRAP
mouse lines, as well as electrophysiological studies of each
cell type. Finally, the profiling of only translated mRNA pools
will more accurately reflect actual protein levels in a cell than
does conventional gene expression profiling, which relies on to-
tal mRNA pools.
The TRAP approach thus overcomes limitations of previous
mRNA-tagging methods that have targeted other RNA-binding
proteins, of which only poly(A)-binding protein (PABP) has
been used in vivo for tissue-specific studies (Roy et al., 2002;
Figure 6. Expression of EGFP-L10a in the Chat and Pcp2 bacTRAP
Lines
(A) Immunohistochemistry to EGFP in adult sagittal sections from the Chat
bacTRAP line DW167.
(B) Indirect immunofluorescent characterization of Chat bacTRAP line DW167
brain stem facial motor nucleus: EGFP staining (left panel), Chat staining (mid-
dle panel), and merge (right panel, with 20 mm scale bar).
(C) Immunohistochemistry to EGFP in adult sagittal sections from the Pcp2
bacTRAP line DR166.
(D) Indirect immunofluorescent characterization of Pcp2 bacTRAP line DR166
Purkinje cell neurons: EGFP staining (left panel), Calbindin-D28K staining
(middle panel), and merge (right panel, with 20 mm scale bar).Kunitomo et al., 2005), and which requires crosslinking of the
tagged PABP to mRNA (and its inherent artifacts) because of
its loose association with mRNA. The use of tagged ribosomal
proteins to purify translating polysomes from yeast as well as
plant cells has recently been reported (Inada et al., 2002; Zanetti
et al., 2005), although in these cases, cell-specific targeting to
obtain cell-specific translational profiles was not attempted.
Figure 7. TRAP Profiles Recapitulate Known Cell-Specific Markers
and Reveal New Ones for Four Distinct Cell Types
Scatterplots of Drd1a , Drd2, Chat, and Pcp2 bacTRAP data compared to a
reference mRNA sample reveal hundreds of genes enriched in each cell type
(A–D). Green circles indicate Affymetrix biotinylated spike-in controls, blue cir-
cles indicate known cell-specific markers, and red circles indicate probesets
for known glial genes (negative controls; Table S26). Lines on either side of
the diagonal mark 2-fold enrichment. Axes are labeled for expression in
powers of ten. Venn diagrams of the top 1000 enriched probesets (with
expression value cutoff > 100) for each cell type reveal that each cell type
has a unique pattern of enriched genes (E–H).Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc. 745
From our own experience, we know that adapting this methodol-
ogy to cell-specific targeting is not trivial, particularly for applica-
tions in the mammalian CNS, with its far more difficult conditions
of low expression, limited material, and contamination by blood,
myelin, and other biological factors. As a result of the optimiza-
tion reported here, the TRAP translational profiling methodology
is now extremely robust to these conditions and broadly applica-
ble (Doyle et al., 2008, accompanying paper).
Furthermore, the TRAP approach was able to identify all
previously known, well-studied striatonigral- and striatopalli-
dal-enriched genes (with one exception: the striatonigral-
enriched muscarinic receptor M4 [Chrm4] [Ince et al., 1997],
for which probesets on the Affymetrix Mouse 430 2.0 GeneChips
gave very little signal; however, real-time PCR analysis of Chrm4
expression demonstrated clear enrichment of Chrm4 mRNA in
our striatonigral bacTRAP cell sample [Table S3]). These results
stand in distinction to a recent microarray study of FACS-sorted
MSNs (Lobo et al., 2006), in which well-known positive-control
genes (e.g., Chrm4, Pdyn, Drd1a, and Drd2) were not identified
as differentially expressed on microarrays, and 16 of the 21
mRNAs reported in that study as striatopallidal-enriched in adult
MSNs could not be confirmed in our analysis. Furthermore, we
report here hundreds of distinguishing transcripts not identified
in that study.
More importantly, our translational profiling analysis of striatal
MSN subtypes has identified novel physiological differences be-
tween striatonigral and striatopallidal cells, which may provide
new therapeutic targets for various neurological diseases asso-
ciated with pathophysiology in the striatum. As one example, we
demonstrate that striatopallidal cells selectively express Gpr6
and that they correspondingly display a cell type-specific release
of intracellular Ca2+ in response to sphingosine 1-phosphate. A
second example of the distinct properties of these medically im-
portant cell types is provided by our studies of psychostimulant
drug action, which give molecular and physiological evidence for
upregulation of GABAA receptor subunits in striatonigral neurons
after chronic cocaine administration.
The results presented here demonstrate that the TRAP trans-
lational profiling methodology provides an enabling technology
for studies of the biology of specific cell types in even the most
heterogeneous cell populations, such as those that occur in
the CNS. We have identified numerous distinguishing molecu-
lar characteristics among four distinct neuronal populations,
including two closely related, critical cell types and have dem-
onstrated that the TRAP methodology can be employed to
analyze physiological adaptations of specific cell types
in vivo. An accompanying study (Doyle et al., 2008) has dem-
onstrated the general applicability of the TRAP methodology
by characterizing additional CNS cell types, each of which ex-
hibits an enormously complex and cell-type specific molecular
phenotype.
EXPERIMENTAL PROCEDURES
Generation of Mouse Lines
BAC transgenic mice were produced according to published protocols (Gong
et al., 2003), with the exception that the EGFP-L10a transgene was used in
place of EGFP.746 Cell 135, 738–748, November 14, 2008 ª2008 Elsevier Inc.Purification of mRNA from bacTRAP Mice
For striatonigral or striatopallidal translated mRNA purification, mice were de-
capitated, and the striata of seven bacTRAP transgenic mice were quickly
manually dissected. Pooled striatal tissue was immediately homogenized in
ice-cold polysome extraction buffer (10 mM HEPES [pH 7.4], 150 mM KCl,
5 mM MgCl2, 0.5 mM dithiothreitol, 100 mg/ml cycloheximide, protease inhib-
itors, and recombinant RNase inhibitors) with a motor-driven Teflon glass
homogenizer. Homogenates were centrifuged for 10 min at 2000 3 g, 4C,
to pellet large cell debris, and NP-40 (EMD Biosciences, San Diego, CA) and
1,2-Diheptanoyl-sn-Glycero-3-Phosphocholine (DHPC; Avanti Polar Lipids,
Alabaster, AL) were added to the supernatant at a final concentration of 1%
and 30 mM, respectively. After incubation on ice for 5 min, the clarified lysate
was centrifuged for 10 min at 13,0003 g to pellet unsolubilized material. Goat
anti-GFP (custom made) -coated protein G Dynal magnetic beads (Invitrogen,
Carlsbad, CA) were added to the supernatant, and the mixture was incubated
at 4C with end-over-end rotation for 30 min. Beads were subsequently
collected on a magnetic rack, washed three times with high-salt polysome
wash buffer (10 mM HEPES [pH 7.4], 350 mM KCl, 5 mM MgCl2, 1% NP-40,
0.5 mM dithiothreitol, and 100 mg/ml cycloheximide) and immediately placed
in TriZol-LS reagent (Invitrogen) and chloroform to extract the bound rRNA
and mRNA from polysomes. After extraction, RNA was precipitated with
sodium acetate and Glycoblue (Ambion, Austin, TX) in isopropanol overnight
at 80C, washed twice with 70% ethanol, resuspended in water, and further
purified with an Rneasy Micro Kit (QIAGEN, Valencia, CA) with in-column
DNase digestion. For the purification of translated mRNAs from brain stem
cholinergic motor neurons (from the Chat bacTRAP line) or cerebellar Purkinje
neurons (from the Pcp2 bacTRAP line), nearly identical purifications as
outlined above were performed, with a few minor modifications (see the
Supplemental Experimental Procedures).
Microarray Data Normalization and Analysis
Three biological replicates were performed for each experiment. Quantitative
PCR reactions were performed to validate array results with an independent
biological source and amplification methodology (see the Supplemental
Experimental Procedures). Striatonigral and striatopallidal GeneChip CEL files
were imported into Genespring GX 7.3.1 (Agilent Technologies, Santa Clara,
CA) and processed with the GC-RMA algorithm, and expression values on
each chip were normalized to that chip’s 50th percentile. Data were converted
to log2 scale and filtered to eliminate genes with intensities in the lower range.
A moderated two-tailed paired t test was performed with the Limma package
from the Bioconductor project (http://www.bioconductor.org/). The p value of
the moderated t test was adjusted for multiple hypothesis testing, controlling
the false discovery rate (FDR) with the Benjamini-Hochberg procedure. We
then selected all genes that had an FDR less than 0.1 (10%) and fold change
larger than 1.5. Other comparisons were performed as described in detail in
the Supplemental Experimental Procedures.
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The data discussed in this publication have been deposited in NCBI’s Gene
Expression Omnibus (GEO) (Edgar et al., 2002) and are accessible through
GEO SuperSeries accession number GSE13394 (http://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE13394).
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